Jonathan B. Rome serves as Executive at Boston Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jonathan B. Rome has executed 1 insider transactions totaling $625.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 13, 2012 involved purchasing 1,250,000 shares valued at $625.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 13, 2012 | BTHE | $625.0K | Purchase | 1,250,000 | $0.50 | Discretionary |
Jonathan B. Rome currently holds 1,258,000 shares of Boston Therapeutics, Inc. (BTHE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan B. Rome has been a net buyer of BTHE stock. They have purchased $625.0K and sold $0 worth of shares.
Jonathan B. Rome's most recent insider trade was on Nov 13, 2012, when they purchased 1,250,000 shares at $0.50 per share.
Get notified when new Form 4 filings are submitted